CAMP4 is latest biotech to eye IPO, while Upstream spells out $182M plans

CAMP4 is latest biotech to eye IPO, while Upstream spells out $182M plans

Submitted by admin on October 7, 2024 - 9:58pm
Source: 
Fierce Biotech
News Tags: 
CAMP4 Therapeutics
IPOs
Upstream Bio
RNA
Headline: 
CAMP4 is latest biotech to eye IPO, while Upstream spells out $182M plans
snippet: 

RNA biotech CAMP4 Therapeutics has marked out plans for a $67 million IPO, with inflammation-focused Upstream Bio pegging its own ambitions at $182 million.

Do Not Allow Advertisers to Use My Personal information